Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > hot off the press.

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Jun 30, 2023 5:15pm

270 Views

Post# 35523051

RE:hot off the press.

Nice to see the GLP toxicology study moving onto the front burner. The sooner they start a phase 1b for gbm or nsclc the better.

The Company intends to use the proceeds of the Offering for the following:

Good Laboratory Practice ("GLP") toxicology study for intravenous installation of Rutherrin® intended for the treatment of Non-Small Lung Cancer ("NSCLC") and Glio Blastoma Multiforme ("GBM")......................................................................................

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism